Tuesday, June 2, 2026

A single protein may be holding back CAR T cancer therapy

A newly identified protein may be one of the biggest obstacles holding CAR T-cell therapy back. Researchers found that NFIL3 causes these engineered immune cells to become exhausted and lose their cancer-fighting power over time. When NFIL3 was disabled, the cells remained stronger for longer and controlled tumors more effectively in animal models.

from Top Health News -- ScienceDaily https://ift.tt/WukVy2Y
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discovered the brain doesn't make decisions the way we thought

A new study suggests the brain begins making decisions much earlier than scientists previously thought. Researchers found that even primary ...